Skip to content

The diagnostic accuracy of Virtual Touch IQ in distinguishing benign from malignant lesions in breast

The diagnostic accuracy of Virtual Touch IQ in distinguishing benign from malignant lesions in breast - ELAN

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40711
Enrollment
200
Registered
2014-09-08
Start date
2015-02-25
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast lesions breast tumor

Interventions

None listed

Sponsors

Jeroen Bosch Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a lesion in the breast, detected by ultrasound, age greater than 18 years ability to give written informed consent

Exclusion criteria

Exclusion criteria: Patient refusal Typical simple cyst at ultrasound

Design outcomes

Primary

MeasureTime frame
With this study we will investigate whether it is possible to dituinguish benign from malignant lesions by measuring the shear wave velocity with Virtual Touch IQ.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)